ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,715.73
      0.23%
      US Tech 100
      19,301.20
      0.02%
      Dow Jones
      42,122.40
      0.14%
      Brent Oil
      73.325
      -0.76%
      Bitcoin
      63,302.38
      -0.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sun BioPharma Inc (SNBP) Quote

      Sun BioPharma Inc

      Sun BioPharma Inc (SNBP)

      SNCF Mobilites Medium-term Notes 1.10% until 25may31
      3.45
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.45
      Bid
      3.09
      Ask
      3.95
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      17.692M
      Previous Close
      3.45
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      5,128,000
      Dividend Yield
      -
      PE Ratio
      -0.23
      Earnings Per Share (EPS)
      -4.93
      Revenue
      -
      Net Profit
      -25.26M

      About Sun BioPharma Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Headquarters
      Dover, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      SNBP Latest News

      More News

      Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Lin...

      MINNEAPOLIS, Dec. 08, 2020 (GLOBE NEWSWIRE) --  Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of...

      December 08 2020
      GlobeNewswire Inc.

      Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.

      MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

      December 01 2020
      GlobeNewswire Inc.

      Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results

      MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

      November 12 2020
      GlobeNewswire Inc.

      Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference

      MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with...

      November 10 2020
      GlobeNewswire Inc.

      Sun BioPharma, Inc. Schedules Conference Call on November 12, 2020 to Report 2020 Third Quarter Financial Results

      MINNEAPOLIS, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with...

      November 02 2020
      GlobeNewswire Inc.

      Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and Warrants

      MINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

      September 01 2020
      GlobeNewswire Inc.

      China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product

      Basic Insurance to Cover 90 Percent of China's Urban Population of 600 Million by the End of 2010 NANTONG, China, Feb. 1 /PRNewswire-Asia/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the...

      February 01 2010
      PR Newswire (US)

      Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril

      NANTONG, China, Jan. 25 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC:SNBP) (BULLETIN BOARD: SNBP) is pleased to announce that its production...

      January 25 2010
      PR Newswire (US)

      Sinobiopharma Announces Second Quarter 2010 Financial Results

      Revenue Increases to Approximately $2.1 Million; Net Income Increases to Approximately $1.1 Million NANTONG CITY, China, Jan. 19 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin...

      January 19 2010
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.30
      (124.53%)
      		163.64M
      RSLSReShape Lifesciences Inc
      $ 10.53
      (62.10%)
      		2.77M
      LASELaser Photonics Corporation
      $ 16.7884
      (61.27%)
      		9.24M
      TGLTreasure Global Inc
      $ 1.082
      (59.05%)
      		131.31M
      UXINUxin Ltd
      $ 2.39
      (50.79%)
      		14.91M
      ELABElevai Labs Inc
      $ 0.1102
      (-60.64%)
      		14.51M
      FRGTFreight Technologies Inc
      $ 0.0806
      (-29.17%)
      		22.68M
      ZJYLJin Medical International Ltd
      $ 2.8907
      (-29.15%)
      		767.41k
      ADTXAditxt Inc
      $ 0.2745
      (-28.25%)
      		2.28M
      BNZIBanzai International Inc
      $ 4.1799
      (-26.54%)
      		1.21M
      XPONExpion360 Inc
      $ 0.1046
      (23.35%)
      		374.5M
      KAVLKaival Brands Innovations Group Inc
      $ 1.30
      (124.53%)
      		163.64M
      NVDANVIDIA Corporation
      $ 115.8435
      (-0.13%)
      		133.72M
      TGLTreasure Global Inc
      $ 1.082
      (59.05%)
      		131.31M
      INTCIntel Corporation
      $ 22.686
      (3.87%)
      		124.32M

      SNBP Discussion

      View Posts
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
      SNBP $3.05,monsta run ahead
      👍️0

      Your Recent History

      NASDAQ
      SNBP
      Sun BioPharma
      Delayed Upgrade Clock